 Recursion to open office space within Mila and build machine learning team to focus on some of drug discoverys most challenging problems MONTRÉAL, June 23, 2021 PRNewswire -- Recursion NASDAQ: RXRX, a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering, today announced a multi-year collaboration with Mila, the Quebec Artificial Intelligence Institute, to accelerate Recursions machine learning capabilities. Recursion is executing at the forefront of multiple technical fields including biology, chemistry, automation, engineering and data science, said Recursion Co-Founder and CEO Chris Gibson. 